Non-drug rehabilitation for gait abnormality of Parkinson's disease: a review based on ClinicalTrials.gov
10.3969/j.issn.1006-9771.2023.07.011
- VernacularTitle:帕金森病步态异常非药物康复循证研究：基于ClinicalTrials.gov数据库分析
- Author:
Jingxuan WANG
1
;
Diyang LÜ
1
;
Boyan FANG
1
Author Information
1. Beijing Rehabilitation Hospital, Capital Medical University, Beijing 100144, China
- Publication Type:Journal Article
- Keywords:
Parkinson's disease;
rehabilitation;
clinical trials;
clinical trial registration platform
- From:
Chinese Journal of Rehabilitation Theory and Practice
2023;29(7):816-821
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate the current trend of non-drug therapy for gait abnormality of Parkinson's disease. MethodsThe clinical trials about non-drug therapy for gait abnormality of Parkinson's disease were retrieved from the clinical trial registration platform ClinicalTrials.gov, from inception to October 25th, 2022. The records were screened by two researchers independently, and the registration time, registration count, sample sizes, interventions, primary outcome measurements and study design, etc., were summarized and analyzed, according to the PICOS principle. ResultsA total of 218 eligible records were included. The registration count increased in recently years. Almost all of the trials (93.6%) were with a relatively small sample size less than 100, mainly 21 to 30 cases. The major intervention approach was the neuromodulation technique, however, virtual reality and robot-assisted gait training were coming to use in recent years. The primary outcome measurements were the clinical scales, the questionnaires and the exercise examinations. Randomized parallel controlled trials were the most (111, 50.9%). ConclusionThe number of non-drug therapy for gait abnormality of Parkinson's disease increased year by year. The new technologies such as virtual reality and robot-assisted gait training may be used more in the future.
